Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Opinion in Infectious Diseases
|
October 7, 2017
Prospects for adoptive T-cell therapy for invasive fungal disease
Gloria Castellano-Gonzalez, Leighton E Clancy, David Gottlieb
Journal of Medical Virology
|
April 19, 2005
Human enterovirus isolates from an outbreak typed using heteroduplex mobility analysis
Leighton E Clancy, Maria E Craig, Peter A White, et al.
Antimicrobial Agents and Chemotherapy
|
August 31, 2006
High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity
Louisa A Jones, Leighton E Clancy, William D Rawlinson, et al.
Current Hematologic Malignancy Reports
|
June 23, 2019
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
Wei Jiang, Barbara Withers, Gaurav Sutrave, et al.
Emerging Infectious Diseases
|
July 19, 2005
Norovirus recombination in ORF1/ORF2 overlap
Rowena A Bull, Grant S Hansman, Leighton E Clancy, et al.
Journal of Virology
|
July 19, 2013
Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses
Selmir Avdic, John Z Cao, Brian P McSharry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 6, 2013
Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution
Leighton E Clancy, Emily Blyth, Renee M Simms, et al.
Clinical & Translational Immunology
|
October 26, 2020
<i>Ex vivo</i> enrichment of PRAME antigen-specific T cells for adoptive immunotherapy using CD137 activation marker selection
Koon H Lee, Kavitha Gowrishankar, Janine Street, et al.
Clinical & Translational Immunology
|
July 10, 2020
Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells
Helen M McGuire, Simone Rizzetto, Barbara P Withers, et al.
American Journal of Hematology
|
May 13, 2022
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant
David J Gottlieb, Gaurav Sutrave, Wei Jiang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Opinion in Infectious Diseases
|
October 7, 2017
Prospects for adoptive T-cell therapy for invasive fungal disease
Gloria Castellano-Gonzalez, Leighton E Clancy, David Gottlieb
Journal of Medical Virology
|
April 19, 2005
Human enterovirus isolates from an outbreak typed using heteroduplex mobility analysis
Leighton E Clancy, Maria E Craig, Peter A White, et al.
Antimicrobial Agents and Chemotherapy
|
August 31, 2006
High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity
Louisa A Jones, Leighton E Clancy, William D Rawlinson, et al.
Current Hematologic Malignancy Reports
|
June 23, 2019
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
Wei Jiang, Barbara Withers, Gaurav Sutrave, et al.
Emerging Infectious Diseases
|
July 19, 2005
Norovirus recombination in ORF1/ORF2 overlap
Rowena A Bull, Grant S Hansman, Leighton E Clancy, et al.
Journal of Virology
|
July 19, 2013
Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses
Selmir Avdic, John Z Cao, Brian P McSharry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 6, 2013
Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution
Leighton E Clancy, Emily Blyth, Renee M Simms, et al.
Clinical & Translational Immunology
|
October 26, 2020
<i>Ex vivo</i> enrichment of PRAME antigen-specific T cells for adoptive immunotherapy using CD137 activation marker selection
Koon H Lee, Kavitha Gowrishankar, Janine Street, et al.
Clinical & Translational Immunology
|
July 10, 2020
Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells
Helen M McGuire, Simone Rizzetto, Barbara P Withers, et al.
American Journal of Hematology
|
May 13, 2022
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant
David J Gottlieb, Gaurav Sutrave, Wei Jiang, et al.
Page
of 2